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eorganization of actomyosin is an essential process
for cell migration and myosin regulatory light chain
(MLC
 
20
 
) phosphorylation plays a key role in this
process. Here, we found that zipper-interacting protein (ZIP)
kinase plays a predominant role in myosin II phosphorylation
in mammalian ﬁbroblasts. Using two phosphorylation site-
speciﬁc antibodies, we demonstrated that a signiﬁcant
portion of the phosphorylated MLC
 
20
 
 is diphosphorylated
and that the localization of mono- and diphosphorylated
myosin is different from each other. The kinase responsible
R
 
for the phosphorylation was ZIP kinase because (a) the
kinase in the cell extracts phosphorylated Ser19 and Thr18
of MLC
 
20
 
 with similar potency; (b) immunodepletion of ZIP
kinase from the cell extracts markedly diminished its
myosin II kinase activity; and (c) disruption of ZIP kinase
expression by RNA interference diminished myosin phos-
phorylation, and resulted in the defect of cell polarity and
migration efﬁciency. These results suggest that ZIP kinase is
critical for myosin phosphorylation and necessary for cell
motile processes in mammalian ﬁbroblasts.
 
Introduction
 
Phosphorylation of the myosin regulatory light chain
(MLC
 
20
 
) is critical for the contractile activity in smooth
muscle and motile events in nonmuscle cells (Hartshorne,
1987; Kamm and Stull, 1989; Tan et al., 1992). The
phosphorylation of MLC
 
20
 
 at Ser19 and Thr18 activates the
motor activity of smooth muscle and nonmuscle myosin II
(Ikebe and Hartshorne, 1985b; Ikebe et al., 1986; Ikebe and
Reardon, 1990), whereas the phosphorylation of Ser1/Ser2
and Thr9 rather inhibit the actomyosin ATPase activity
due to the decrease in the affinity for actin (Nishikawa et
al., 1984; Ikebe et al., 1987a). Although Ca
 
2
 
 
 
/CaM-depen-
dent myosin light chain kinase (MLCK) can phosphorylate
Thr18 of MLC
 
20
 
 in addition to Ser19, the rate of phosphor-
ylation of the former site is much slower than the latter site
(Ikebe and Hartshorne, 1985b); therefore, it has been
thought that the phosphorylation at Ser19 is physiologically
an important site for smooth muscle myosin II, thus the
regulation of smooth muscle contraction. On the other
hand, the physiological significance of Thr18 phosphorylation
is obscure. Nevertheless, Thr18 phosphorylation occurs in
vivo and it has been reported that diphosphorylation of
MLC
 
20
 
 at Thr18 and Ser19 occurs in smooth muscle induced
by external stimuli (Colburn et al., 1988; Singer, 1990) and
in nonmuscle cells in conjunction with the cellular shape
change and exocytosis (Itoh et al., 1992; Choi et al., 1994).
It has been demonstrated that diphosphorylation of MLC
 
20
 
at Thr18 and Ser19 increases actomyosin ATPase activity
more than that of monophosphorylation at Ser19 (Ikebe and
Hartshorne, 1985b). Furthermore, the phosphorylation of
myosin at Thr18 in addition to Ser19 significantly stabilizes
the filament formation of myosin II in vitro (Ikebe et al.,
1988). It is likely that Thr18 phosphorylation of MLC
 
20
 
plays a more significant role in nonmuscle cells where the
polymerization–depolymerization of myosin is thought to
be dynamically regulated.
Although MLCK is thought to be responsible for myosin II
phosphorylation, recent studies have suggested that other
protein kinases might also contribute to phosphorylation of
myosin II. Amano et al. (1996) showed that Rho-associated
kinase (Rho-kinase) phosphorylates MLC
 
20
 
 at Ser19. Recently
it was reported that zipper-interacting protein (ZIP) kinase
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(Murata-Hori et al., 1999) and integrin-linked kinase (Deng
et al., 2001) phosphorylate MLC
 
20
 
 at Ser19 and Thr18. In-
terestingly, ZIP kinase phosphorylate Ser19 and Thr18 of
MLC
 
20
 
 with similar potency in contrast to MLCK (Niiro and
Ikebe, 2001). These findings have raised a hypothesis that
myosin II can be phosphorylated by various protein kinases in
cells by diverse stimulations. On the other hand, it has been
realized that the phosphorylation level of myosin II is also
controlled by regulating myosin phosphatase (MLCP). Ki-
mura et al. (1996) showed that the myosin binding subunit
(MBS) of MLCP is phosphorylated by Rho-kinase and the
phosphorylation down-regulates MLCP activity. The phos-
phorylation site of MBS responsible for the down-regulation
of MLCP is Thr641 (rat sequence; Feng et al., 1999) and it
was found subsequently that MBS can be phosphorylated at
Thr641 by various kinases including ZIP kinase like kinase
(MacDonald et al., 2001) and integrin-linked kinase (Kiss et
al., 2002; Muranyi et al., 2002) suggesting that MLCP activ-
ity is regulated via multiple signaling pathways.
Phosphorylation of myosin II has been thought to be crit-
ical for the various actin-based contractile events in nonmus-
cle cells (Tan et al., 1992; Komatsu et al., 2000). Because
the assembly and the motor activity of myosin II is regulated
by MLC
 
20
 
 phosphorylation, the localization of phosphory-
lated MLC
 
20
 
 would reflect the distribution of activated
phosphorylated myosin II in motile cells. A critical question
is whether the localization of myosin II phosphorylated at
only Ser19 and at both Ser19 
 
 
 
 Thr18 of MLC
 
20
 
 are differ-
ent from each other and whether this is related to the func-
tion of myosin at particular cellular compartment, because
the diphosphorylation of MLC
 
20
 
 significantly facilitates the
formation of stable myosin filaments (Ikebe et al., 1988; Ka-
misoyama et al., 1994).
Here, we identified that ZIP kinase is responsible for my-
osin phosphorylation in motile fibroblasts. The present pa-
per also showed that there is a significant amount of diphos-
phorylated myosin in motile cells whose localization is
different from the monophosphorylated one and plays an
important role in the maintenance of cell morphology and
migration. ZIP kinase phosphorylating Thr18 and Ser19 of
MLC
 
20
 
 with the same potency is primarily responsible for
this event.
 
Results
 
Production of the antibodies that specifically recognize 
diphosphorylated MLC
 
20
 
Different states of myosin phosphorylation (single Ser19 or
both Ser19 and Thr18 sites) exhibited considerable differ-
ences both in the actin activated ATPase activity and fila-
ment stability of myosin in vitro (Ikebe and Hartshorne,
1985b). To investigate the functional difference in diphos-
Figure 1. Specificity of pTS Ab against the diphosphorylated 
regulatory light chain of myosin. (A) Unphosphorylated or phos-
phorylated MLC20 either by MLCK or PKC were separated by 
urea/glycerol gel (top), followed by immunoblotting with pTS Ab 
(middle). Lane 1, unphosphorylated MLC20; lane 2, monophos-
phorylated MLC20 by MLCK; lane 3, diphosphorylated MLC20 by 
MLCK; lane 4, mono- and diphosphorylated MLC20 by PKC; lane 5, 
mono- and diphosphorylated MLC20 by ZIP kinase. Note that pTS Ab 
reacted with diphosphorylated MLC20, but not monophosphorylated 
MLC20 and phosphorylated MLC20 by PKC. (B) Immunoblot of whole 
cell lysates with pTS Ab. The whole cell lysates of (lane 1) REF-2A 
fibroblast or (lane 2) NRK epithelial cells were analyzed by immuno-
blotting with pTS Ab. (Right) Immunoblot with anti-MLC20 mAb, 
showing the total amount of MLC20.
Figure 2. Distribution of mono- and diphosphorylated myosin II 
in motile fibroblasts. (A) REF-2A fibroblasts were stained with pTS 
Ab and pSer19 Ab. Panels a–i show the immunofluorescent images 
of motile fibroblasts. (a and h), pTS Ab; (d and g), pSer19 Ab; (b and 
e) Texas red–phalloidin; (c and f) DIC image. A motile REF-2A cells 
were subjected to double staining with (g) pSer19 Ab and (h) pTS 
Ab. (i) was merged image of g and h. Arrows in c and f show the 
direction of cell locomotion. Bar, 20  m. Note the strong signal of 
pTS Ab at the tail portion of the motile cells and relatively weak at 
the anterior region, whereas the signals of pSer19 Ab at the posterior 
and anterior regions are nearly the same. (B) The whole cell lysates of 
REF-2A fibroblast were subjected to urea/glycerol gel electrophoresis, 
followed by immunoblotting with (lane 1) anti-MLC20 pAb, (lane 2) 
pSer19 Ab, and (lane 3) pTS Ab. 
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phorylated and monophosphorylated myosin II in cell mo-
tile process, we developed the specific antibodies differen-
tially recognizing the mono- and diphosphorylated myosin.
Previously, we produced the antibodies (pSer19 Ab) that
recognized the phosphorylated MLC
 
20
 
 of myosin II at Ser19
(Komatsu et al., 2000). Although this antibody is useful to
detect the Ser19 phosphorylated myosin II, it cannot dis-
tinguish between the singly phosphorylated MLC
 
20
 
 and
diphosphorylated MLC
 
20
 
 at both Ser19 and Thr18, al-
though the antibodies recognizes the single phosphorylated
MLC
 
20
 
 at Ser19 stronger than the diphosphorylated MLC
 
20
 
.
To overcome this problem, we developed the antibodies that
recognize diphosphorylated MLC
 
20
 
 but not MLC
 
20
 
 phos-
phorylated at only Ser19.
The specificity of pTS Ab was examined by immunoblot
analysis. MLC
 
20
 
 was phosphorylated by MLCK, PKC, and
ZIP kinase. The unphosphorylated, mono-, and diphosphor-
ylated MLC
 
20
 
s were separated on an urea/glycerol gel (Fig. 1
A, top), followed by immunoblotting with pTS Ab (Fig. 1
A, middle). The pTS Ab only recognized the diphosphory-
lated MLC
 
20
 
 by MLCK and ZIP kinase, but did not recog-
nized unphosphorylated, monophosphorylated by MLCK
and ZIP kinase, or monophosphorylated (Thr9) MLC
 
20
 
 by
PKC. It was shown previously that ZIP kinase phosphory-
lates Ser19 and Thr18 of MLC
 
20
 
 with same rate constant
thus yielding the same amount of Ser19 phosphorylated
MLC
 
20
 
 and Thr18 phosphorylated MLC
 
20
 
 (Niiro and
Ikebe, 2001). Therefore, the results shown in Fig. 1 indi-
cate that pTS Ab specifically recognizes diphosphorylated
MLC
 
20
 
. Fig. 1 B shows the immunoblotting of whole cell ly-
sates of REF-2A fibroblast and NRK epithelial cells. The
result indicates that the antibodies specifically recognize
MLC
 
20
 
 but not other proteins. pTS Ab and pSer19 Ab rec-
ognizing the Ser19 phosphorylated MLC
 
20
 
 were used as
probes to determine the distribution of di- and monophos-
phorylated myosin II at MLC
 
20
 
 in motile fibroblasts.
 
Distribution of di- and monophosphorylated MLC
 
20
 
 
in motile fibroblasts
 
Fig. 2 A shows the immunofluorescent images of motile fi-
broblast cells. A REF-2A fibroblast cell exhibits a polarized
cell shape that is characteristic of the motile cells (Fig. 2 A,
c). The staining with pTS Ab (Fig. 2 A, a) revealed filamen-
tous localizations of diphosphorylated MLC
 
20
 
 and this was
superimposed with F-actin localization (Fig. 2 A, b). The
strong signal was detected at the peripheral tail portion in
motile cells, whereas the signal at the anterior region was
weak (Fig. 2 A, a). On the other hand, the signals by pSer19
Ab that recognized the phosphorylated MLC
 
20
 
 of myosin at
Ser19 appeared to be strong at both posterior and anterior
regions (Fig. 2 A, d). This observation is consistent with that
of Matsumura et al. (1998). To further clarify the differen-
tial localization of the mono- and diphosphorylated MLC
 
20
 
,
the motile cells were subjected to dual immunostaining with
pTS Ab and pSer19 Ab. The cells were first stained with
the polyclonal pTS Ab and then followed by monoclonal
pSer19 Ab. The merged image of pSer19 Ab (Fig. 2 A, g,
green) and pTS Ab (Fig. 2 A, h, red) signals shows that the
diphosphorylated MLC
 
20
 
 was accumulated at the tail (Fig. 2
A, i). In contrast, the ruffling membrane area of anterior re-
gion (Fig. 2 A, i, arrowheads) appeared greenish, indicating
that monophosphorylated MLC
 
20
 
 is enriched more than
diphosphorylated MLC
 
20
 
 in this area. It should be noted
Figure 3. Differential localization of mono- and 
diphosphorylated myosin II in migrating COS 7 cells. 
COS 7 cells were stained with pTS Ab (a, green) 
and pSer19 Ab (g, green), and with Texas red–
phalloidin (b and h, red). Panels c and i show merged 
image of a and b, and g and h, respectively. Panels 
d–f were double staining with pSer19 Ab (d, green) 
and pTS Ab (e, red). Panel f show merged image 
of d and e. Arrows indicate the membrane ruffling 
area in the leading edge. Bar, 16  m. 
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that diphosphorylated MLC
 
20
 
 shows strong stress fiber local-
ization. To monitor the level of mono- and diphosphory-
lated MLC
 
20
 
 in cells, the total homogenates were subjected
to urea/glycerol gel electrophoresis. As shown in Fig. 2 B,
significant level of diphosphorylated MLC
 
20
 
 was observed. It
should be noted that a significant level of unphosphorylated
MLC
 
20
 
 was present, whereas a significant level of MLC
 
20
 
was diphosphorylated. pTS antibody only recognized the
diphosphorylated MLC
 
20
 
 of total cell homogenates. The re-
sult is consistent with Fig. 1 and further warrants that pTS
antibody staining shows the localization of diphosphorylated
MLC
 
20
 
 in cells.
The subcellular distribution of MLC
 
20
 
 in different phos-
phorylation states was also observed with spreading COS 7
cells. The diphosphorylated MLC
 
20
 
 was colocalized with ac-
tin stress fibers (Fig. 3, b and c), but not the membrane ruf-
fling area at the leading edge (Fig. 3, a and c). In contrast,
the significant level of pSer19 Ab immunoreactivity was ob-
served at the membrane ruffling area in addition to the stress
fibers (Fig. 3, d–i). The fluorescence signal of monophos-
phorylated myosin II at the membrane ruffling area divided
by entire signal was approximately six times higher than that
of diphosphorylated myosin II. These observations indicate
that the localization of mono- and diphosphorylated myosin
in migrating cells is different to each other. Because diphos-
phorylation of MLC
 
20
 
 stabilizes thick filaments (Ikebe et al.,
1988), the result suggests that diphosphorylated myosin
forming stable filaments are incorporated into large stress
fiber structure, whereas monophosphorylated myosin is
present at the area where dynamic rearrangement of myosin
structure takes place.
 
Inhibition of myosin phosphorylation and disruption of 
myosin filaments in vivo
 
Previously, it was reported for NIH3T3 fibroblasts that
MLCK is responsible for the phosphorylation of myosin at
the peripheral region and that the assembly of stress fiber at
the central region is mediated by Rho-kinase based upon the
use of the specific kinase inhibitors (Totsukawa et al., 2000).
Thus, we wondered whether the level of diphosphorylated
myosin at both regions is reduced by inhibition of these ki-
nases. The effect of kinase inhibitors on the localization of
diphosphorylated myosin in REF-2A cells is shown in Fig.
4. In control cells, diphosphorylated myosin was strongly lo-
calized at the thick stress fibers in nonmotile cells (Fig. 4 A,
a; Fig. 2). Rho-kinase inhibitor, Y27632, induced to disas-
semble stress fibers (Fig. 4 A, d) and simultaneously de-
creased the extent of the diphosphorylated myosin filaments
(Fig. 4 A, c). On the other hand, ML-7 significantly de-
creased the diphosphorylation of myosin at the central re-
gion of the cell (Fig. 4 A, e), but a significant level of diphos-
phorylated myosin II was observed at the cell peripheral
region. Consistent with these observations, myosin phos-
phorylation was diminished by 
 
 
 
60% for monophosphory-
Figure 4. Effect of the protein kinase inhibitors on the localization 
of diphosphorylated myosin II in REF-2A cells. (A) REF-2A cells 
treated with 0.4% DMSO (a and b), 10  M Y27632 (c and d) or 40 
 M ML-7 (e and f). The cells were stained with pTS Ab (a, c, and e) 
and with Texas red–phalloidin (b, d, and f). Bar, 20  m. The whole 
cell lysates treated with 10  M Y27632, 40  M ML-7 or 0.4% 
DMSO were subjected to Western blotting with (B) pSer19 Ab (top), pTS Ab (middle), or MLC20 Ab (bottom), respectively. (C) Immunoblotting 
with pThr 799 Ab (top) or MBS Ab (bottom). The amount of phosphorylated myosin II (B) or MBS (C) was determined by scanning densitometry 
(NIH image program). The densities of the phospho-antibody bands were normalized with those of pan antibody bands. The values shown 
are means   SD from three independent experiments. 
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lation and 40% for diphosphorylation by treatment with 40
 
 
 
M ML-7 (Fig. 4 B). On the other hand, the treatment of
the cells with 10 
 
 
 
M Y27632 decreased both the mono- and
diphosphorylated MLC
 
20
 
 to 20% of that of control (Fig. 4
B). The phosphorylation level of MBS at Thr799, that was
one of the major phosphorylation sites by Rho-kinase
(Kawano et al., 1999), was also decreased to 21% (Fig. 4 C).
In contrast, treatment with ML-7 had no detectable effect
on MBS phosphorylation at Thr799 (Fig. 4 C). It was re-
ported previously that Y27632 activates MLCP activity (Ue-
hata et al., 1997) and the present result was consistent with
this earlier result. Therefore, the results suggest that the de-
crease in MLC
 
20
 
 phosphorylation by Y27632 is due to the
activation of MLCP by Rho-kinase–induced MBS dephos-
phorylation, whereas ML-7 decreases MLC
 
20
 
 phosphoryla-
tion due to the inhibition of myosin II kinase but not the
change in MLCP activity because ML-7 did not change the
phosphorylation level of MBS. To verify whether the de-
crease in MLC
 
20
 
 phosphorylation by ML-7 is due to the in-
hibition of MLCK, we examined the effect of wortmannin
on MLC
 
20
 
 phosphorylation in cells. Wortmannin treatment
did not change MLC
 
20
 
 phosphorylation level (unpublished
data), suggesting that ML-7–induced decrease in MLC
 
20
 
phosphorylation is due to the inhibition of other kinases.
 
Myosin phosphorylation activity in cell extracts
 
To identify the candidate kinases for MLC
 
20
 
 phosphoryla-
tion, myosin II kinase activity was measured with cell ex-
tracts of REF-2A cells. Purified myosin II was incubated
with the cell extracts in the presence of MLCP inhibitor
(Microcystin-LR) and then the phosphorylation of myosin
II was examined by Western blot analysis using pSer19 Ab
or pTS Ab. As shown in Fig. 5 A, the cell extracts produced
significant level of diphosphorylated MLC
 
20
 
. The extents of
mono- and diphosphorylated MLC
 
20
 
 were estimated by us-
ing urea/glycerol gel electrophoresis. The diphosphorylated
MLC
 
20
 
 appeared whereas a significant portion of MLC
 
20
 
 re-
mained unphosphorylated (Fig. 5 A). The results suggest
that the protein kinases responsible for MLC
 
20
 
 phosphoryla-
tion phosphorylate Ser19 and Thr18 with similar potency.
Because it is known that MLCK and Rho-kinase phos-
phorylate MLC
 
20
 
 in vitro, we examined whether these ki-
nases are responsible for MLC
 
20
 
 phosphorylation. We first
examined whether or not these kinases are extracted. The to-
tal cell homogenates and the cell extracts were subjected to
Western blot analysis with ROK
 
 
 
 Ab and MLCK Ab as
probes (Fig. 5 B). The signals of whole lysates and cell ex-
tracts in Fig. 5 B are similar to each other, indicating that
majority of these kinases are recovered in the cell extracts.
As shown in Fig. 5 C, Rho-kinase inhibitor, Y27632
(maximal 100 
 
 
 
M), had no significant effect on myosin
phosphorylation in the cell extracts. To examine whether
Rho-kinase in the cell extracts is active, we used MBS as a
substrate for Rho-kinase (Kimura et al., 1996). MBS was in-
cubated with the extracts and followed by immunoblotting
with pThr 641 Ab or pThr 799 Ab that recognizes the phos-
phorylated MBS at the two Rho-kinase–induced phosphor-
ylation sites, Thr641 or Ser799, respectively (Kawano et
al., 1999). As shown in Fig. 5 D, the cell extracts phos-
phorylated MBS, and the phosphorylation was inhibited
by Y27632. The results indicate that there is significant
Rho-kinase activity in the cell extracts, but Rho-kinase does
not significantly phosphorylate myosin.
In contrast, the MLCK inhibitor, ML-7, inhibited myosin
II phosphorylation by the cell extracts (Fig. 5 C). Myosin
phosphorylation in Ca
 
2
 
 
 
 by the cell extracts was decreased
by 50% with 30 
 
 
 
M ML-7 (Fig. 5 C), whereas the phos-
phorylation by isolated Rho-kinase was not significantly in-
Figure 5. Myosin phosphorylation 
activity in cell extracts. (A) Time course 
of myosin phosphorylation by cell 
extracts and GST-ZIP kinase. The reaction 
was terminated at indicated time. Phos-
phorylated myosin was subjected to 
urea/glycerol gel electrophoresis, followed 
by immunoblotting with anti-MLC20 
Ab. (B) Extraction of ROK  and MLCK. 
Whole lysates and cell extracts were 
subjected to Western blotting with ROK  
Ab and MLCK Ab. (C) Effects of kinase 
inhibitors and EGTA on myosin phos-
phorylation activity in cell extracts. 
Myosin was phosphorylated with cells 
extracts and the signals were detected 
with pSer19 Ab (middle) or pTS Ab 
(bottom). Transfer membranes were 
stained with ponceau S (top). Assay was 
done in 0.2 mM CaCl2 except for lane 9. 
(D) Rho-kinase activity in cell extracts. 
MBS was phosphorylated with cell extracts 
in the presence of Y27632 and phosphor-
ylated MBS was detected with pThr 641 
Ab or pThr 799 Ab. (E) Effects of kinase 
inhibitors on myosin phosphorylation by 
Rho-kinase (middle) or MLCK (bottom). 
The signal was detected with pSer19 Ab. 
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hibited by ML-7 even with 100 
 
 
 
M (Fig. 5 E, middle).
However, myosin phosphorylation activity in the cell ex-
tracts was not affected by the elimination of Ca
 
2
 
 
 
 (Fig. 5 C,
 
 
 
EGTA) and this is contradictory to the fact that MLCK
requires Ca
 
2
 
 
 
/CaM for its activity. One possibility to ac-
count for this discrepancy is that MLCK might become the
constitutively active form by proteolysis during the prepara-
tion steps of cell extracts (Ikebe et al., 1987b). To address
this possibility, MLCK-specific peptide inhibitor, SM-1,
which strongly inhibits both native and constitutively active
MLCK (Ikebe et al., 1987b), was examined for the inhibi-
tion of the kinase activity in the cell extracts. As shown in
Fig. 6, SM-1 peptide inhibitor did not inhibit the kinase ac-
tivity in the cell extracts, whereas it significantly inhibited
the 61-kD constitutively active form of MLCK. These re-
sults indicate that major myosin II kinase activity in the cell
extract was neither Rho-kinase nor MLCK. These results to-
gether with the results of Figs. 4–6 suggest that ML-7 sensi-
tive kinases other than Ca
 
2
 
 
 
/CaM-dependent MLCK are re-
sponsible for myosin phosphorylation in fibroblast cells.
 
ZIP kinase is involved in myosin phosphorylation 
activity in cell extracts
 
The above results suggest that the myosin II kinase responsi-
ble for the phosphorylation of myosin II in the motile cells
can phosphorylate Ser19 and Thr18 with similar potency.
Previously, it was reported that ZIP kinase phosphorylates
MLC20 of myosin at Thr18 and Ser 19 with the same rate
constant in a Ca
2 -independent manner and that ZIP kinase
is not inhibited by Y27632 (Niiro and Ikebe, 2001). There-
fore, we examined the time course of the production of
mono- and diphosphorylated MLC20 by the cell extracts.
This time course was compared with that of ZIP kinase. The
myosin II kinase in the cell extracts showed the similar pat-
tern of mono- and diphosphorylated MLC20 production as
ZIP kinase (Fig. 5 A). The present results together with the
previous findings raise a possibility that ZIP kinase is in-
volved in the phosphorylation of myosin II. To address
whether ZIP kinase activity is responsible for myosin II
phosphorylation in cells, the cell extracts were immunode-
pleted by ZIP kinase Ab. As shown in Fig. 7 A, the immu-
nodepletion markedly diminished the myosin II phosphor-
ylation activity of the cell extracts as compared with the
mock-treated extracts in both Ca
2  and EGTA. The im-
munodepletion eliminated 75% of the total myosin II kinase
Figure 6. Effects of SM-1 peptide inhibitor of MLCK on myosin 
MLC20 phosphorylation by cell extracts. Myosin II was phosphory-
lated by cell extracts or Ca
2 /CaM-independent 61-kD MLCK 
fragment in the presence of SM-1 peptide. (bottom) pSer19 Ab; 
(top) ponceau S staining.
Figure 7. Determination of ZIP kinase as myosin II 
MLC20 kinase in cultured cells. (A) Cell extracts were 
subjected to immunodepletion with either nonspecific 
rabbit IgGs (mock) or anti-ZIP kinase Ab. (Left) Western 
blot of myosin II phosphorylated by either mock- or ZIP 
kinase–depleted cell extracts in EGTA or Ca
2  with pSer19 
Ab or pTS Ab. (Right) Decrease in myosin II phosphory-
lation by immunodepletion in EGTA condition. The 
values shown are means   SD from three independent 
experiments. (B) Myosin II was phosphorylated by immuno-
precipitated ZIP kinase. (C) Effects of ML-7 on myosin II 
phosphorylation by ZIP kinase. Myosin phosphorylated 
by GST-ZIP kinase was examined with pSer19 Ab. 
(D) Localization of ZIP kinase in REF-2A fibroblasts. (a) ZIP 
kinase Ab; (b) Texas red–phalloidin; (c) merged image of 
a and b. Arrows indicate the colocalization of ZIP kinase 
with actin fibers. Bar, 20  m.Myosin phosphorylation by ZIP kinase | Komatsu and Ikebe 249
activity of Ser19 phosphorylation and 90% of diphosphory-
lation in the cell extracts, respectively. The immunodepleted
sample was examined for MLCK and Rho-kinase level by
Western blot, but no detectable decrease in these kinases was
observed (Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200309056/DC1). Similar decrease in my-
osin II kinase activity by ZIP kinase immunodepletion was
also found with NIH3T3 and COS 7 cells (Fig. S1 B). Fig.
7 B shows that ZIP kinase obtained by immunoprecipitation
from the cell extracts phosphorylated MLC20 of myosin II.
Interestingly, myosin phosphorylation by ZIP kinase was
significantly inhibited by ML-7 (Fig. 7 C) with dose depen-
dence similar to that for the inhibition of the myosin II ki-
nase in the cell extracts (Fig. 5 C). Fig. 7 D shows the sub-
cellular localization of ZIP kinase in REF-2A cells. ZIP
kinase localized at stress fiber as well as cell cortical region
where diphosphorylated myosin II is present and colocalized
with actin structure. These results strongly support that ZIP
kinase is a major kinase responsible for myosin II phosphor-
ylation in mammalian cultured cells.
Microinjection and depletion of ZIP kinase result in the 
change in myosin phosphorylation in vivo
To test whether ZIP kinase is responsible for the change in
myosin II diphosphorylation in cells, we microinjected ex-
ogenous ZIP kinase into REF-2A cells. Microinjection of
GST-ZIP kinase into the serum-starved REF-2A cells mark-
edly increased diphosphorylated MLC20 probed by pTS Ab
(unpublished data).
To further evaluate the role of ZIP kinase in myosin II
phosphorylation in mammalian cultured cells, we dimin-
ished ZIP kinase expression by using RNA interference
(RNAi) technique. NIH3T3 cells were transfected with
small interfering RNA (siRNA) oligoduplex corresponding
to the coding region of the ZIP kinase mRNA. The siRNA-
transfected cells were harvested and subjected to Western
blot analysis using the specific antibodies as probes. Immu-
noblots showed that two molecular mass proteins recognized
by ZIP kinase Ab (58 and 34 kD, respectively) were dimin-
ished in the cells transfected with siRNA (Fig. 8 A, left). It
was reported that there are two ZIP kinase variants having
different molecular weights (Kawai et al., 1998; Kogel et al.,
1998; MacDonald et al., 2001), and it is expected that these
two molecular weight bands are corresponding to the longer
and shorter forms of ZIP kinase variants. Consistently, the
myosin II kinase activity in cytosol fraction that is predomi-
nantly due to ZIP kinase activity was significantly decreased.
Myosin II kinase activity in cytoplasmic fractions from cells
transfected with either mock or ZIP kinase siRNA were
measured. The activity was significantly diminished com-
pared with that of mock-transfected cells (Fig. 8 D; 67% de-
crease). The extent of the decrease in activity was compara-
ble to the decrease in the expression level of ZIP kinase
(65% decrease). The siRNA specific to ZIP kinase attenu-
Figure 8. Effect of silencing of ZIP kinase on myosin phosphorylation. (A) Immunoblot 
analysis of total cell lysates from transfected NIH3T3 fibroblasts cells with mock or 
ZIP kinase siRNA duplex (54 h after transfection), using (left) anti-ZIP kinase Ab and 
(right) pSer19 Ab, pTS Ab, MLC20 Ab,  -actin Ab, ROK  Ab, pThr 799 Ab, pThr 641 Ab, 
and MLCK Ab. Arrowheads indicate the ZIP kinase bands. (B) Immunostaining of NIH3T3 
fibroblasts cells transfected with siRNA duplex. pTS Ab (green), Texas red–phalloidin 
(red) and paxillin (gray). Bar, 20  m. (C) Immunostaining of myosin heavy chain IIB. Bar, 20  m. (D) Decrease in myosin kinase activity by 
suppression of ZIP kinase by RNAi. 54 h after transfection, cytoplasmic fractions from either mock- or siRNA-transfected cells were prepared 
and myosin kinase activity was measured as described in Materials and methods. The samples were separated by SDS-PAGE and followed by 
immunoblotting with pSer19 Ab and pTS Ab. The values shown are mean   SD from three independent experiments.250 The Journal of Cell Biology | Volume 165, Number 2, 2004
ated neither Rho-kinase nor MLCK (Fig. 8 A, right). Con-
sistently, MBS phosphorylation at Thr799, a Rho-kinase–
specific site, was unaffected by the ZIP kinase–specific
siRNA (Fig. 8 A, right). We also found that the siRNA
treatment did not affect MBS phosphorylation at Thr641,
another Rho kinase site. It was reported that ZIP kinase-like
kinase can phosphorylate MBS at Thr641 in vitro (Mac-
Donald et al., 2001). As shown in Fig. 8 A, both mono- and
diphosphorylated MLC20 were markedly decreased in ZIP
kinase siRNA-transfected cells compared with that of mock-
transfected cells. These results suggest that the decrease in
myosin phosphorylation via the suppression of ZIP kinase
causes failure of direct myosin phosphorylation by ZIP ki-
nase but not down-regulation of MLCP through the MBS
phosphorylation. Fig. 8 B shows immunostaining of the
siRNA-transfected cells with the phosphorylation site-spe-
cific antibodies. Consistent with the Western blot analysis,
the intensity of immunofluorescence signals of pTS Ab was
significantly reduced in the ZIP kinase siRNA-transfected
cells (Fig. 8 B, e) compared with the control cells (Fig. 8 B,
a). The decrease in MLC20 phosphorylation in the siRNA-
transfected cells was observed at the central stress fibers (Fig.
8 B, e), similar to that observed with ML-7–treated cells
(Fig. 4 A). It was also recognized that the filamentous struc-
ture of myosin II was low in the cells transfected with ZIP
kinase siRNA (Fig. 8 C, c). This is consistent with the lower
myosin II phosphorylation in siRNA-transfected cells be-
cause it is known that myosin II phosphorylation induces
the filament formation of myosin (Ikebe and Hartshorne,
1985b; Sellers et al., 1985). To warrant that the effect of
ZIP kinase siRNA on the decrease in MLC20 phosphoryla-
tion is due to the elimination of ZIP kinase, we examined
whether human ZIP kinase that is resistant to siRNA can
rescue the decrease in MLC20 phosphorylation of the cells
treated with ZIP kinase siRNA. The cells treated by mouse
ZIP kinase siRNA were transfected by human ZIP kinase
and MLC20 phosphorylation level was monitored. The cells
expressing human GFP-ZIP kinase showed strong diphos-
phorylation signals at the stress fiber (Fig. S2, available at
http://www.jcb.org/cgi/content/full/jcb.200309056/DC1).
The focal adhesion was also reduced in the siRNA-trans-
fected cells (Fig. 8 B, g; decreased by 45.3   9.6%). Consis-
tent with this observation, a large number of nonadhesive
cells were observed when siRNA-treated cells were cultured
on noncoated or poly-D-lysine–coated glass bottom culture
dishes (unpublished data). These results suggest that ZIP ki-
nase plays a critical role in the change in MLC20 phosphory-
lation and the regulation of cytoskeletal structure in mam-
malian cultured cells.
Attenuation of ZIP kinase expression inhibits cell 
polarity and migration
It has been known that myosin II phosphorylation plays a
role in cell migration, therefore, if ZIP kinase is a major fac-
tor regulating myosin II phosphorylation, it is anticipated
that the attenuation of ZIP kinase expression decreases cell
migration. First, we examined the migratory activity of ZIP
kinase siRNA-transfected cells using fibronectin-coated mi-
crochambers. Migration efficiency of mock- and siRNA-
transfected cells was estimated as ratio of cell migration ob-
served in the presence and the absence of chemotactic factor,
PDGF. siRNA-transfected cells consistently showed lower
migration efficiency than mock-transfected cells (Fig. 9 A;
Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200309056/DC1).
As shown in Fig. 9 B, significant number of fibroblasts
transfected with ZIP kinase siRNA exhibited an elongated
shape (Fig. 9 B, right, arrows). The elongated morphology
of the siRNA-transfected cells was observed with differential
interference contrast (DIC). We also examined for the ex-
tent of myosin phosphorylation of the elongated cells by im-
munostaining with pTS Ab and found that there was a dra-
matic decrease in myosin phosphorylation (unpublished
data). On the other hand, mock-transfected cells displayed
normal morphology (Fig. 9 B, left, arrowheads) and virtually
no elongated cell shape was observed. Cells transfected with
nonspecific siRNA (corresponding to human ZIP kinase se-
quence having four nucleotide substitutions) had also nor-
mal morphology and did not affect on myosin phosphory-
lation (unpublished data). These results suggest that the
decrease in the motility activity of the ZIP kinase–depleted
cells is due to the significant change in the cytoskeletal struc-
ture caused by the decrease in myosin II phosphorylation.
These results also suggest that ZIP kinase plays a critical role
during the cell spreading.
Discussion
Specific localization of mono- and diphosphorylated 
myosin II during cell migration
Biochemical studies have revealed that myosin II phosphory-
lated at both Ser19 and Thr18 of MLC20 is different from
Figure 9. ZIP kinase is necessary for 
establishment of cell polarity and 
migration. (A) Inhibition of PDGF-induced 
migration rate by ZIP kinase siRNA. Figure 
shows the mean   SD of three indepen-
dent experiments. (B) Cell morphology of 
mock- or ZIP kinase siRNA-transfected 
cells. Arrowheads and arrows indicate 
the migrating cells and elongated cells, 
respectively. Bar, 80  m.Myosin phosphorylation by ZIP kinase | Komatsu and Ikebe 251
that phosphorylated at only Ser19 in both actin activated
ATPase activity and myosin filament formation (Ikebe and
Hartshorne, 1985b; Sellers et al., 1985; Ikebe et al., 1986;
Ikebe and Reardon, 1990). This raises the possibility that
the diphosphorylated myosin II and monophosphorylated
myosin II have a distinct role in cell motile and contractile
processes. It is anticipated that the different properties of
myosin II molecules is reflected by the distinct cellular local-
ization. Using two phosphorylation site-specific antibodies,
we found that mono- and diphosphorylated myosin II are
differently localized in migrating cells. Diphosphorylated
MLC20 was predominantly found at the posterior peripheral
region, whereas monophosphorylated MLC20 was found at
the anterior region of the cells. Furthermore, monophosphor-
ylated myosin II localized at the membrane ruffle area of
the leading edge, whereas diphosphorylated MLC20 did not.
It is known that the rapid reorganization of actin takes place
at the membrane ruffling area of the leading edge. There-
fore, it is reasonable to assume that myosin II filaments at
reading edge are also under rapid reorganization. On the
other hand, diphosphorylated myosin II that forms stable
filaments is recruited at the peripheral tail portion and de-
velop the force necessary for the retraction of the tail region.
This view is consistent with biochemical properties of myo-
sin II that diphosphorylation of MLC20 stabilizes the forma-
tion of large myosin filaments, whereas monophosphory-
lated myosin II tends to form smaller filaments suggesting
that it is under the equilibrium between monomeric myosin
and filamentous myosin (Ikebe and Hartshorne, 1985b;
Sellers et al., 1985; Ikebe et al., 1986; Ikebe and Reardon,
1990). It is plausible that diphosphorylated myosin filaments
at the peripheral tail portion might be involved in mainte-
nance of a cell morphology during migration, whereas mono-
phosphorylated myosin filaments at the leading edge gener-
ates the force necessary for cell migration.
Protein kinases responsible for the phosphorylation of 
myosin II in migrating cells
A critical question to understand the regulation of myosin II
phosphorylation in migrating cells is the identity of the
protein kinases phosphorylating MLC20. MLCK has been
thought to be a predominant kinase responsible for myosin
II phosphorylation in mammalian nonmuscle cells. This is
partly because the possibility of other kinases to be physio-
logically important myosin II kinase has been overlooked.
Recently, it was shown that ZIP kinase can phosphorylate
MLC20 at Ser19 and Thr18. A critical finding is that ZIP ki-
nase unlike MLCK phosphorylates Ser19 and Thr18 with
same rate constant yielding diphosphorylated MLC20 effec-
tively. Successful production of the antibody recognizing
diphosphorylated MLC20 enables us to study the nature of
critical myosin II kinase in nonmuscle cells. Our results in-
dicate that the protein kinases responsible for the phosphor-
ylation of myosin II are the kinases that phosphorylate
MLC20 at Ser19 and Thr18 with similar rate constant be-
cause (a) a significant level of the diphosphorylated MLC20
was present in the cells; (b) the kinases in the cell extract
produced diphosphorylated MLC20 at the time when a sig-
nificant portion of unphosphorylated MLC20 remained un-
like MLCK; and (c) SM-1 as well as wortmannin, MLCK
inhibitors, had no detectable effect on myosin II kinase ac-
tivity in the cell extract. It has been shown in vitro that Rho-
kinase can phosphorylate myosin II at Ser19 (Amano et al.,
1996). The incubation of the cells with Rho-kinase in-
hibitor, Y27632, a specific inhibitor of Rho-kinase, signifi-
cantly inhibited MLC20 phosphorylation in cells. However,
Y27632 did not inhibit myosin phosphorylation activity in
the cell extracts. We think that the inhibition of MLC20
phosphorylation in cells by Y27632 is not due to the inhibi-
tion of myosin II kinase but due to the activation of MLCP.
Supporting this view, we found that MLCP activity ob-
tained from the cells treated with Y27632 was 1.8 times
higher than that obtained from the untreated cells (unpub-
lished data). It has been reported that the inhibition of
MLCP by phosphatase inhibitor or microinjection of MBS
Ab into mammalian cultured cells increases MLC20 phos-
phorylation (Chartier et al., 1991; Totsukawa et al., 2000).
Together with our present paper, we think that Rho-kinase
mainly contributes to myosin phosphorylation through the
regulation of MLCP but not direct myosin II phosphoryla-
tion in vivo.
Interestingly, ML-7 diminished the myosin II kinase ac-
tivity in the cell extracts. Consistently, ML-7 also attenuated
the MLC20 phosphorylation in cells. However, the kinase ac-
tivity in the cell extracts was neither inhibited by EGTA nor
SM1 peptide, suggesting that ML-7 inhibit the kinases other
than MLCK in the cell extract. Supporting this idea, ML-7
inhibited the purified ZIP kinase with similar concentration
dependence against the inhibition of the kinases in the cell
extracts. Recently, it was reported that ZIP kinase like kinase
purified in smooth muscle is inhibited by ML-9 that is simi-
lar to ML-7 and the present result is consistent with this ob-
servation (Borman et al., 2002). The present result indicates
that ML-7 is not specific to MLCK but also inhibits ZIP ki-
nase, therefore, earlier results using ML-7 as a MLCK–spe-
cific inhibitor may need to be reevaluated.
To further ensure the importance of ZIP kinase for myo-
sin phosphorylation in mammalian cultured cells, we have
used several approaches. First, identity of the major myosin
II kinase in the cell extracts as ZIP kinase was demonstrated
by the immunodepletion experiment. The depletion of ZIP
kinase by the specific antibodies markedly reduced the myo-
sin II kinase activity in the cell extracts, indicating that ZIP
kinase is the major kinase responsible for myosin phosphor-
ylation in the cell extracts. Consistently, the immunoprecip-
itation of the extracts using the ZIP kinase Ab recovered the
myosin II kinase activity. Second, the microinjection of ZIP
kinase into serum-starved NIH3T3 cells induced myosin
phosphorylation (unpublished data). Supporting the idea
that ZIP kinase participates in myosin phosphorylation, the
overexpression of ZIP kinase in HeLa cells induced myosin
phosphorylation (Murata-Hori et al., 2001). It was also re-
ported that ZIP kinase increases myosin phosphorylation of
smooth muscle strips and induces contraction (Niiro and
Ikebe, 2001). These previous results support the idea that
ZIP kinase can increase myosin II phosphorylation and acti-
vate the contractile activity of actomyosin.
Further evidence that ZIP kinase is critical for myosin
phosphorylation in mammalian cells was obtained using a
recently developed siRNA technique (Fire et al., 1998). The252 The Journal of Cell Biology | Volume 165, Number 2, 2004
depletion of endogenous ZIP kinase in NIH3T3 fibroblasts
by the specific siRNA decreased mono- and diphosphoryla-
tion of MLC20 without changing myosin expression level.
Furthermore, immunocytochemical analysis revealed that
diphosphorylated myosin filaments at the central region
were remarkably diminished by transfection of the ZIP ki-
nase siRNA. Interestingly, myosin phosphorylation at the
cortical region was not completely abolished in the ZIP ki-
nase–depleted cells, suggesting that other kinases may be in-
volved in myosin phosphorylation at this region. Recently, it
was shown that MLCK contributes to myosin phosphoryla-
tion at the cortical region but not in the center (Totsukawa
et al., 2000, 2004), therefore, myosin phosphorylation at the
cell cortical region may be in part mediated by MLCK.
ZIP kinase is important for NIH3T3 cell polarity 
and migration
We found that the disruption of ZIP kinase causes the change
in cell morphology and migratory behavior of NIH3T3 fibro-
blasts. It is widely believed that the reorganization of actomy-
osin is an essential process for progress of cell migration and
that myosin phosphorylation is involved in this process. In
the present paper, we found that the interference of ZIP ki-
nase inhibits cell migration activity. Interestingly, attenuation
of ZIP kinase induced elongated cell morphology. We think
that the decrease in myosin phosphorylation via the depletion
of ZIP kinases causes failure of stable myosin filament forma-
tion in stress fiber structure and thus changing cytoskeletal
structure and cell morphology. This might allow cells to be-
come elongated and lose motility.
In summary, based upon the present paper, we propose
that ZIP kinase promotes dynamic rearrangement of myosin
structure through the myosin phosphorylation in motile fi-
broblast cells and contributes to the cell motile processes in-
volving in spreading and migration.
Materials and methods
Materials
Smooth muscle myosin (Ikebe and Hartshorne, 1985a) and MLCK (Ikebe et
al., 1987a) were prepared from turkey gizzards. Ca
2 /CaM-independent
61-kD MLCK and Xenopus oocyte CaM were prepared as described previ-
ously (Chien and Dawid, 1984; Ikebe et al., 1987b). Rat MBS cDNA and
ROK  cDNA were gifts from P. Cohen (University of Dundee, Dundee,
Scotland, UK) and T. Leung (National University of Singapore, Singapore),
respectively, and cloned into pFASTBAC HT plasmid. Rho-kinase and GST
tagged ZIP kinase were purified from Sf9 cells with Ni
2 -nitrilotriacetic
acid-agarose (QIAGEN) or glutathione-Sepharose 4B as described previ-
ously (Niiro and Ikebe, 2001). SM-1 peptide was synthesized as described
previously (Ikebe et al., 1987b). Y27632 was provided by Yoshitomi Phar-
maceutical Industries, Ltd., and ML-7 was purchased from Calbiochem.
Antibodies
A phosphopeptide KKRPQRAphosphoTSNVFAMC was coupled to keyhole
limpet hemocyanin at COOH-terminal cysteine residue. A pTS Ab was af-
finity purified using the phosphopeptide and then absorbed with unphos-
phopeptide. A pSer19 Ab, ZIP kinase Ab, and phosphorylation-specific Ab
against MBS at Thr 641 or Ser799 were described previously (Komatsu et
al., 2000; Niiro and Ikebe, 2001; Takizawa et al., 2002). A rabbit Ab
against heavy chain of myosin IIB, MLC20, and MLCK were provided by R.
Adelstein (National Institutes of Health, Bethesda, MD), J. Stull (University
of Texas Southwestern Medical Center, Dallas, TX), and P. de Lanerolle
(University of Illinois, Chicago, IL), respectively. Anti-MLC20, MBS, ROK ,
 -actin, and paxillin Abs were purchased from Sigma-Aldrich, Covance
Research Products Inc., and Transduction Laboratories, respectively.
Cell culture, microinjection, and transfection
REF-2A cells (a gift from F. Matsumura, Rutgers University, Piscataway, NJ)
and NIH3T3 fibroblast cells were maintained in DME containing 10%
newborn calf serum. NRK cells (NRK52E; a gift from Y.-L. Wang, Univer-
sity of Massachusetts, Worcester, MA) and COS 7 cells were cultured in
F12 medium (Sigma-Aldrich) containing 10% FBS (GIBCO BRL), 2 mM
L-glutamine or DME containing 10% FBS, respectively. Microinjection
was performed using a micromanipulator (Transjector 5246; Eppendorf).
0.1mg/ml of ZIP kinase was coinjected with FITC-dextran.
For RNAi, the selected sequences were submitted to a BLAST search to
ensure that only ZIP kinase gene was targeted. The targeting sequence of
mouse ZIP kinase (AB007143), AAGACAGATGTGGTGCTGATC, corre-
sponding to the coding region 256–276 of ZIP kinase was used for siRNA
and synthesized by Dharmacon Research. Double strand siRNA was pre-
pared according to the manufacturer’s protocol (Dharmacon), and trans-
fected using Lipofectamine 2000 (Invitrogen). As a negative control
(nonspecific siRNA), human ZIP kinase (AB022341) siRNA (AAGACG-
GACGTGGTCCTCATC) was used. siRNA-transfected cells were cultured
on the fibronectin (10  g/ml)-coated glass coverslips.
Preparation of cell extracts
REF-2A cells were washed and then lysed in buffer I (50 mM Tris-HCl, pH
7.5, 5 mM MgCl2, 0.1 mM EGTA, 5 mM DTT, 5% glycerol, 0.2 mM N -p-
tosyl-L-lysine chloromethl ketone, 0.2 mM N-tosyl-L-phenylal-anine chlo-
romethl ketone, 2 mM PMSF, and 0.05% NP-40). After added 0.4 M NaCl,
cell lysates were sonicated and centrifuged at 10,000 g for 15 min. Protein
concentration was determined by the method of Bradford (1976) by using
BSA as a standard. For NIH3T3 cells, nuclear and cytosol fractions were
prepared from cells treated with siRNA using Nuclear/Cytosol Fraction-
ation Kit (BioVision, Inc.).
Immunoprecipitation and immunodepletion
The cell extracts were incubated with either nonspecific rabbit IgGs or
anti-ZIP kinase Ab at 4 C for 3 h and then protein A-Support (Bio-Rad Lab-
oratories) was added. The immunocomplex was centrifuged, washed three
times with wash buffer (0.1 M KCl and Tris-HCl, pH 8.8), and two times
with buffer B and used for myosin phosphorylation assay.
Biochemical procedures
Urea/glycerol PAGE (Perrie and Perry, 1970) and SDS-PAGE (Laemmli,
1970) were performed as described previously. MLC20 was phosphorylated
by MLCK and PKC (Ikebe and Hartshorne, 1985a; Ikebe et al., 1987a). Im-
munoblotting was done as described previously using nitrocellulose mem-
branes (Yano et al., 1993; Komatsu et al., 2000). In vitro phosphorylation
was performed using buffer containing 30 mM NaCl, 5 mM MgCl2, 1  M
microcystin-LR, 0.2 mM ATP, and 30 mM Tris-HCl, pH 7.5, and 0.2 mM
CaCl2 for buffer A and 5 mM EGTA for buffer B. Myosin (0.4 mg/ml) or
MBS was phosphorylated in the presence of kinase inhibitors (Y27632,
ML-7 in buffer A or SM-1 peptide in buffer B) by 0.2mg/ml of cell extracts
or exogenous kinases (1  g/ml Rho-kinase, 1  g/ml CaM, and 1  g/ml
MLCK in buffer A, Ca
2 /CaM-independent 1  g/ml MLCK or 1  g/ml GST-
ZIP kinase in buffer B) in the presence of kinase inhibitors. The reaction
was done for 15 min at 30 C, and then phosphorylated MLC20 or MBS was
detected by Western blotting analysis.
Immunofluorescence staining and image processing
Immunocytochemistry was performed as described previously (Komatsu et
al., 2000). Cells were stained with Texas red–conjugated phalloidin (Mo-
lecular Probes) for F-actin. For double staining with pSer19 Ab and pTS
Ab, the cells were first stained with pTS Ab for 6 h at 4 C and then fol-
lowed by pSer19 Ab overnight. DIC and fluorescence images were viewed
using a DM IRB laser scanning confocal microscope (Leica) controlled by
TCS SP II systems (Leica). All images were taken with same laser out put to
directly compare the fluorescence signal intensities. Images were pro-
cessed using Adobe
® Photoshop
® 5.5 software.
Migration assays
Cell migration was studied using transwell migration chambers (6.5-mm
diam; 8- m pore size; COSTAR Corp.) coated on both sides of the mem-
brane with 10  g/ml fibronectin in PBS for 16 h at 4 C. Mock- or siRNA-
transfected NIH3T3 cells were cultured for 24 h in DME supplemented
with 0.1% newborn calf serum and then detached by trypsinization. Assays
were performed by the addition of the cells (5   10
4 cells/well) to the up-
per compartment of the transwell chamber and allowed to migrate to the
membrane in the bottom chambers containing medium supplemented withMyosin phosphorylation by ZIP kinase | Komatsu and Ikebe 253
20 ng/ml PDGF for 3 h. Migrated cells attached to the bottom surface of the
membrane were fixed in methanol, stained with Giemsa, and counted.
Online supplemental material
Fig. S1 shows that immunodepletion of ZIP kinase had no effect on the ex-
pression level of both ROK  and MLCK (A) and that ZIP kinase was re-
sponsible for myosin II phosphorylation in the cell extracts from different
cell types (B). Fig. S2 shows that the decrease in myosin II phosphorylation
by mouse ZIP kinase siRNA was rescued by expression of human ZIP ki-
nase. Fig. S3 shows the wound healing assay indicating that the migra-
tion of ZIP kinase siRNA-transfected cells is slower than that of mock-
transfected cells. Online supplemental material is available at http://www.
jcb.org/cgi/content/full/jcb.200309056/DC1.
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